During the last session, TherapeuticsMD Inc (NASDAQ:TXMD)’s traded shares were 7.2 million, with the beta value of the company hitting 1.19. At the end of the trading day, the stock’s price was $1.57, reflecting an intraday gain of 82.56% or $0.71. The 52-week high for the TXMD share is $2.75, that puts it down -75.16 from that peak though still a striking 55.41% gain since the share price plummeted to a 52-week low of $0.70. The company’s market capitalization is $18.11M, and the average intraday trading volume over the past 10 days was 0.82 million shares, and the average trade volume was 28.88K shares over the past three months.
TherapeuticsMD Inc (TXMD) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. TXMD has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
TherapeuticsMD Inc (NASDAQ:TXMD) trade information
TherapeuticsMD Inc (TXMD) registered a 82.56% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 82.56% in intraday trading to $1.57, hitting a weekly high. The stock’s 5-day price performance is 41.43%, and it has moved by 14.60% in 30 days. Based on these gigs, the overall price performance for the year is -32.62%. The short interest in TherapeuticsMD Inc (NASDAQ:TXMD) is 21273.0 shares and it means that shorts have 0.99 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 49.33%.
TXMD Dividends
TherapeuticsMD Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
TherapeuticsMD Inc (NASDAQ:TXMD)’s Major holders
TherapeuticsMD Inc insiders own 1.71% of total outstanding shares while institutional holders control 44.53%, with the float percentage being 45.30%. RUBRIC CAPITAL MANAGEMENT LP is the largest shareholder of the company, while 44.0 institutions own stock in it. As of 2024-06-30, the company held over 1.19 million shares (or 10.3381% of all shares), a total value of $1.92 million in shares.
The next largest institutional holding, with 0.64 million shares, is of CLEARLINE CAPITAL LP’s that is approximately 5.5205% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.02 million.
